Medi-Span (Wolters Kluwer) Drug Database API

Medi-Span (Wolters Kluwer Health) REST APIs for clinical drug database and pharmacy data platform. Enables AI agents to manage drug-drug interaction checking for clinical decision support, handle drug-allergy and drug-disease contraindication data retrieval for patient safety, access NDC (National Drug Code) and drug product data for pharmacy management, retrieve drug dosing guidelines and pediatric dosing recommendations for clinical applications, manage formulary and drug pricing data for pharmacy benefit management, handle medication therapy management (MTM) and polypharmacy review data, access generic equivalency and drug substitution data for pharmacy cost management, retrieve drug pregnancy and lactation safety data for prescribing support, manage drug supply shortage and discontinuation alert data, and integrate clinical drug data with EHR, pharmacy management, and clinical decision support systems.

Evaluated Mar 07, 2026 (0d ago) vcurrent
Homepage ↗ Developer Tools medi-span drug-database clinical-data pharmacy drug-interactions wolters-kluwer healthcare-it
⚙ Agent Friendliness
54
/ 100
Can an agent use this?
🔒 Security
74
/ 100
Is it safe for agents?
⚡ Reliability
72
/ 100
Does it work consistently?

Score Breakdown

⚙ Agent Friendliness

MCP Quality
15
Documentation
68
Error Messages
65
Auth Simplicity
75
Rate Limits
62

🔒 Security

TLS Enforcement
95
Auth Strength
72
Scope Granularity
62
Dep. Hygiene
70
Secret Handling
72

Clinical drug data. HIPAA, SOC2. API key. US. Drug interaction and medication data.

⚡ Reliability

Uptime/SLA
75
Version Stability
78
Breaking Changes
72
Error Recovery
65
AF Security Reliability

Best When

A healthcare organization, pharmacy system, or clinical application using Medi-Span wants AI agents to automate drug interaction checking, prescription validation, formulary management, and clinical drug data integration.

Avoid When

PATIENT SAFETY RISK: Drug interaction and contraindication data is used for patient safety decisions — automated clinical drug checking without licensed pharmacist or prescriber review violates clinical safety standards. False negatives on drug-drug interactions can cause patient harm. Automated drug substitution and formulary overrides without clinical review creates prescribing errors. Clinical drug data has regulatory requirements for licensed healthcare use.

Use Cases

  • Checking drug interactions from clinical decision support agents
  • Validating prescriptions from pharmacy verification agents
  • Retrieving drug pricing from PBM formulary agents
  • Assessing medication safety from clinical pharmacology agents

Not For

  • Consumer drug information without clinical-grade interaction checking
  • Non-pharmacy applications without medication safety and clinical data needs
  • Simple drug lookups without comprehensive drug interaction database

Interface

REST API
Yes
GraphQL
No
gRPC
No
MCP Server
No
SDK
No
Webhooks
No

Authentication

Methods: apikey
OAuth: No Scopes: No

Medi-Span uses API key authentication. Per-organization credentials with licensed data access. Part of Wolters Kluwer Health. REST and flat-file database distribution options. No webhooks — licensed data updates via scheduled refresh. Indianapolis, Indiana HQ (Medi-Span). Clinical drug database licensed for specific healthcare use cases.

Pricing

Model: enterprise
Free tier: No
Requires CC: No

Indianapolis, Indiana. Medi-Span founded 1975. Part of Wolters Kluwer Health (acquired 1999). Clinical drug data market. 2,000+ healthcare organization customers. Drug interaction database licensed for EHR, pharmacy, and PBM integration. Competes with First Databank and Lexicomp for clinical drug database market.

Agent Metadata

Pagination
none
Idempotent
Full
Retry Guidance
Not documented

Known Gotchas

  • PATIENT SAFETY RISK: Drug interaction false negatives are patient safety events; automated CDS using Medi-Span must not suppress or auto-override pharmacist or prescriber review
  • Licensed healthcare use only — Medi-Span data is licensed for specific healthcare use cases; consumer-facing or non-clinical use requires separate licensing review
  • Data update cadence — drug database is updated regularly (weekly/monthly); ensure automated systems consume data updates and don't use stale drug interaction data
  • Severity level interpretation — drug interaction severity ratings require clinical pharmacist interpretation; automated severity-based decisions without pharmacist oversight is inappropriate
  • NDC format complexity — NDC codes have multiple formats (10-digit, 11-digit, formatted with dashes); standardize NDC format before drug lookups to avoid missed matches
  • Clinical liability — automated clinical drug decisions based on Medi-Span data require licensed healthcare professional oversight; data licensor may require confirmation of clinical oversight in agreement

Alternatives

Full Evaluation Report

Comprehensive deep-dive: security analysis, reliability audit, agent experience review, cost modeling, competitive positioning, and improvement roadmap for Medi-Span (Wolters Kluwer) Drug Database API.

AI-powered analysis · PDF + markdown · Delivered within 30 minutes

$99

Package Brief

Quick verdict, integration guide, cost projections, gotchas with workarounds, and alternatives comparison.

Delivered within 10 minutes

$3

Score Monitoring

Get alerted when this package's AF, security, or reliability scores change significantly. Stay ahead of regressions.

Continuous monitoring

$3/mo

Scores are editorial opinions as of 2026-03-07.

6470
Packages Evaluated
26150
Need Evaluation
173
Need Re-evaluation
Community Powered